Melissa P. Andrews
Pfizer (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Lipid metabolism and biosynthesis, Cholinesterase and Neurodegenerative Diseases, Phosphodiesterase function and regulation, Tuberculosis Research and Epidemiology
Most-Cited Works
- → The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agents(2009)45 cited
- → Design and Synthesis of Diazatricyclodecane Agonists of the G-Protein-Coupled Receptor 119(2012)30 cited
- → 1,5-Substituted nipecotic amides: Selective PDE8 inhibitors displaying diastereomer-dependent microsomal stability(2011)26 cited
- → Design and synthesis of potent, orally-active DGAT-1 inhibitors containing a dioxino[2,3-d]pyrimidine core(2011)22 cited
- → Defining the key pharmacophore elements of PF-04620110: Discovery of a potent, orally-active, neutral DGAT-1 inhibitor(2013)21 cited
- → Efficient Synthesis of 4-Amino-2-methoxy-7,8-dihydropyrido[4,3-d]pyrimidin-5-ones: Practical Access to a Novel Chemotype in the Development of DGAT-1 Inhibitors(2012)2 cited
- → Corrigendum to “Defining the key pharmacophore elements of PF-04620110: Discovery of a potent, orally-active, neutral DGAT-1 inhibitor” [Bioorg. Med. Chem. 21 (2013) 5081–5097](2013)1 cited